Literature DB >> 33964699

One-pot synthesis of a self-reinforcing cascade bioreactor for combined photodynamic/chemodynamic/starvation therapy.

Li Zhang1, Zhe Yang1, Wenshan He2, Jinghua Ren3, Chun-Yuen Wong4.   

Abstract

The combination of photodynamic therapy (PDT) and chemodynamic therapy (CDT) have attracted a great deal of interest, but tumor hypoxia and glutathione (GSH) overproduction still limit their further applications. Herein, an intelligent reactive oxygen species (ROS) nanogenerator Ce6/GOx@ZIF-8/PDA@MnO2 (denoted as CGZPM; Ce6, GOx, ZIF-8, PDA, MnO2 are chlorin e6, glucose oxidase, zeolitic imidazolate framework-8, polydopamine and manganese dioxide respectively) with O2-generating and GSH-/glucose-depleting abilities was constructed by a facile and green one-pot method. After intake by tumor cells, the outer MnO2 was rapidly degraded by the acidic pH, and the overexpression of hydrogen peroxide (H2O2) and GSH with abundant Mn2+ and O2 produced would eventually achieve multifunctionality. The Mn2+ acted as an ideal Fenton-like agent and magnetic resonance (MR) imaging contrast agent, while the O2 promoted the PDT via hypoxia relief and facilitated the intratumoral glucose oxidation by GOx for starvation therapy (ST). Benefiting from the GOx-based glycolysis process, sufficient H2O2 was generated to improve the CDT efficacy through Mn2+-mediated Fenton-like reaction. Notably, MnO2 and PDA could decrease the tumor antioxidant activity by consuming GSH, resulting in remarkably enhanced PDT/CDT. Such a novel cascade bioreactor with tumor microenvironment (TME)-modulating capability opens new opportunities for ROS-based and combinational treatment paradigms.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemodynamic therapy; Glutathione-depleting; Magnetic resonance imaging; Photodynamic therapy; Starvation therapy

Year:  2021        PMID: 33964699     DOI: 10.1016/j.jcis.2021.03.173

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  9 in total

Review 1.  Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.

Authors:  Zhiyan Li; Xianghui Li; Shichao Ai; Song Liu; Wenxian Guan
Journal:  Int J Nanomedicine       Date:  2022-06-17

Review 2.  Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapies.

Authors:  Shuang Liang; Guangfu Liao; Wenzhen Zhu; Li Zhang
Journal:  Biomater Res       Date:  2022-07-06

Review 3.  Research Progress on Improving the Efficiency of CDT by Exacerbating Tumor Acidification.

Authors:  Wenting Chen; Jinxi Liu; Caiyun Zheng; Que Bai; Qian Gao; Yanni Zhang; Kai Dong; Tingli Lu
Journal:  Int J Nanomedicine       Date:  2022-06-10

Review 4.  Applications of nanocomposites based on zeolitic imidazolate framework-8 in photodynamic and synergistic anti-tumor therapy.

Authors:  Wen Kang; Ying Tian; Ying Zhao; Xindao Yin; Zhaogang Teng
Journal:  RSC Adv       Date:  2022-06-09       Impact factor: 4.036

5.  Self-amplification of oxidative stress with tumour microenvironment-activatable iron-doped nanoplatform for targeting hepatocellular carcinoma synergistic cascade therapy and diagnosis.

Authors:  Qiao-Mei Zhou; Yuan-Fei Lu; Jia-Ping Zhou; Xiao-Yan Yang; Xiao-Jie Wang; Jie-Ni Yu; Yong-Zhong Du; Ri-Sheng Yu
Journal:  J Nanobiotechnology       Date:  2021-11-08       Impact factor: 10.435

6.  Synthesis of manganese-oxide and palladium nanoparticles co-decorated polypyrrole/graphene oxide (MnO2@Pd@PPy/GO) nanocomposites for anti-cancer treatment.

Authors:  Jiarui Wu; Meng Wang; Yuanjie Pan; Yipeng Pang; Yanyan Tang; Chang Song; Jiahui Zhu; Xian Zhang; Qingli Huang
Journal:  RSC Adv       Date:  2022-08-22       Impact factor: 4.036

Review 7.  Iron-Based Hollow Nanoplatforms for Cancer Imaging and Theranostics.

Authors:  Shun Luo; Shuijie Qin; Gerile Oudeng; Li Zhang
Journal:  Nanomaterials (Basel)       Date:  2022-08-31       Impact factor: 5.719

Review 8.  Nanoscale Zeolitic Imidazolate Framework (ZIF)-8 in Cancer Theranostics: Current Challenges and Prospects.

Authors:  Hongxin Xie; Xinyu Liu; Zhengrong Huang; Liexi Xu; Rui Bai; Fajian He; Mengqin Wang; Linzhi Han; Zhirong Bao; Yuzhou Wu; Conghua Xie; Yan Gong
Journal:  Cancers (Basel)       Date:  2022-08-15       Impact factor: 6.575

Review 9.  Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy.

Authors:  Liang Hong; Jiangmin Li; Yali Luo; Tao Guo; Chenshuang Zhang; Sha Ou; Yaohang Long; Zuquan Hu
Journal:  Biomolecules       Date:  2022-01-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.